Zurich Cantonal Bank
IBRX icon

Zurich Cantonal Bank’s ImmunityBio IBRX Stock Holding History

Zurich Cantonal Bank’s Portfolio IBRX Stock Details IBRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$703K Hold
80,269
– – ﹤0.01% 1756
2026
Q1 		$616K Buy
80,269
+19,858
+33% +$136K ﹤0.01% 1723
2025
Q4 		$120K Buy
60,411
+16,419
+37% +$37.2K ﹤0.01% 2360
2025
Q3 		$108K Hold
43,992
– – ﹤0.01% 2372
2025
Q2 		$116K Hold
43,992
– – ﹤0.01% 2340
2025
Q1 		$132K Buy
43,992
+13,139
+43% +$39.8K ﹤0.01% 2286
2024
Q4 		$79K Sell
30,853
-586
-2% -$2.44K ﹤0.01% 2501
2024
Q3 		$117K Sell
31,439
-54
-0.2% -$250 ﹤0.01% 2369
2024
Q2 		$199K Sell
31,493
-100
-0.3% -$659 ﹤0.01% 2038
2024
Q1 		$170K Buy
31,593
+3,488
+12% +$15.8K ﹤0.01% 2133
2023
Q4 		$141K Buy
28,105
+8,932
+47% +$28K ﹤0.01% 2279
2023
Q3 		$32.4K Hold
19,173
– – ﹤0.01% 2665
2023
Q2 		$53.3K Hold
19,173
– – ﹤0.01% 2602
2023
Q1 		$34.9K Hold
19,173
– – ﹤0.01% 2672
2022
Q4 		$97.2K Buy
19,173
+5,392
+39% +$29.6K ﹤0.01% 2290
2022
Q3 		$68K Hold
13,781
– – ﹤0.01% 2463
2022
Q2 		$51K Hold
13,781
– – ﹤0.01% 2581
2022
Q1 		$77K Sell
13,781
-4,084
-23% -$25.1K ﹤0.01% 2386
2021
Q4 		$109K Buy
17,865
+9,568
+115% +$71.9K ﹤0.01% 2465
2021
Q3 		$81K Buy
8,297
+29
+0.4% +$319 ﹤0.01% 2447
2021
Q2 		$118K Hold
8,268
– – ﹤0.01% 2126
2021
Q1 		$196K Buy
8,268
+4,781
+137% +$124K ﹤0.01% 1785
2020
Q4 		$46K Buy
+3,487
New +$33.5K ﹤0.01% 2454
2017
Q2 		– Sell
-5,487
Closed -$19K – 2545
2017
Q1 		$19K Hold
5,487
– – ﹤0.01% 2323
2016
Q4 		$31K Hold
5,487
– – ﹤0.01% 2057
2016
Q3 		$43K Buy
+5,487
New +$41K ﹤0.01% 1731

Other funds holding IBRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Zurich Cantonal Bank's IBRX Position: Q2 2026 in Review

Zurich Cantonal Bank held its ImmunityBio (IBRX) position steady in Q2 2026 at 80,269 shares worth $703K. The position accounts for ﹤0.01% of the portfolio, ranked #1756.

Zurich Cantonal Bank first reported a position in IBRX in Q3 2016 and has held it in 26 quarters since. 404 funds tracked by Wall St. Rank hold IBRX as of Q2 2026.

  • Zurich Cantonal Bank held 80,269 shares of ImmunityBio worth $703K as of Q2 2026.
  • Zurich Cantonal Bank left its ImmunityBio share count unchanged in Q2 2026.
  • ImmunityBio made up ﹤0.01% of Zurich Cantonal Bank's portfolio in Q2 2026, its #1756 holding.
  • Zurich Cantonal Bank first reported a position in ImmunityBio in Q3 2016 and has held it in 26 quarters since.
  • 404 funds tracked by Wall St. Rank held ImmunityBio as of Q2 2026.

Based on Zurich Cantonal Bank's 13F filing for Q2 2026, filed 12 Aug 2026.